Stocktoria

PharmaCyte Biotech, Inc. PMCB

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2003-09-11

PharmaCyte Biotech, Inc. statistics & valuation

Market cap$8.3M
P / B0.2×
Return on equity-58.3%
Return on capital-14.9%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2017201820192020202120222023202420252026
Operating margin (%)
2017201820192020202120222023202420252026
Return on equity (%)
-54.90% -118.40% -80.70% -75.20% -53.20% -4.70% -5.90% 1.20% 59.10% -58.30% 2017201820192020202120222023202420252026
Shares outstanding
905.3M 1.01B 1.19B 1.1M 1.6M 20.7M 19.5M 9.6M 7.3M 10.7M 2017201820192020202120222023202420252026
Net debt ($)
2017201820192020202120222023202420252026
Share buybacks ($)
2017201820192020202120222023202420252026
Return on assets (%)
-51.30% -106.50% -70.30% -62.10% -48.00% -4.70% -5.90% 0.60% 55.60% -41.50% 2017201820192020202120222023202420252026
Free cash flow margin (%)
2017201820192020202120222023202420252026
Debt / equity (×)
2017201820192020202120222023202420252026
EPS ($)
-$2.45 -$0.27 -$0.22 -$1.80 $3.19 -$2.77 2017201820192020202120222023202420252026

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Return on assets-41.5%55.6%0.6%-5.9%-4.7%-48.0%-62.1%-70.3%-106.5%-51.3%
Return on equity-58.3%59.1%1.2%-5.9%-4.7%-53.2%-75.2%-80.7%-118.4%-54.9%
Current ratio45.287.686.80116.18121.383.141.010.881.996.10

Computed from company filings · US · as of 2025-04-30. Facts plus Stocktoria's own computed scores — not investment advice.